191 related articles for article (PubMed ID: 16690876)
41. [Aortic calcification and matrix metalloproteinases].
Cui X; Wang S; Guo A
Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):347-9. PubMed ID: 11866933
[TBL] [Abstract][Full Text] [Related]
42. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G
Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
[TBL] [Abstract][Full Text] [Related]
43. Aortic calcification produced by vitamin D3 plus nicotine.
Niederhoffer N; Bobryshev YV; Lartaud-Idjouadiene I; Giummelly P; Atkinson J
J Vasc Res; 1997; 34(5):386-98. PubMed ID: 9349732
[TBL] [Abstract][Full Text] [Related]
44. Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves.
Chen W; Kim JD; Schoen FJ; Levy RJ
J Biomed Mater Res; 1994 Dec; 28(12):1485-95. PubMed ID: 7876288
[TBL] [Abstract][Full Text] [Related]
45. Adrenomedullin(27-52) inhibits vascular calcification in rats.
Cai DY; Yu F; Jiang W; Jiang HF; Pan CS; Qi YF; Chang L; Zhao J; Yang JH; Zhu MJ; Jia YX; Geng B; Ma TM; Pang YZ; Tang CS
Regul Pept; 2005 Jul; 129(1-3):125-32. PubMed ID: 15927707
[TBL] [Abstract][Full Text] [Related]
46. Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats.
Adijiang A; Goto S; Uramoto S; Nishijima F; Niwa T
Nephrol Dial Transplant; 2008 Jun; 23(6):1892-901. PubMed ID: 18334529
[TBL] [Abstract][Full Text] [Related]
47. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption.
Price PA; Faus SA; Williamson MK
Arterioscler Thromb Vasc Biol; 2001 May; 21(5):817-24. PubMed ID: 11348880
[TBL] [Abstract][Full Text] [Related]
48. Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension.
Guimaraes DA; Rizzi E; Ceron CS; Oliveira AM; Oliveira DM; Castro MM; Tirapelli CR; Gerlach RF; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2011 May; 108(5):318-25. PubMed ID: 21176109
[TBL] [Abstract][Full Text] [Related]
49. Matrix metalloproteinase inhibitor, doxycycline and progression of calcific aortic valve disease in hyperlipidemic mice.
Jung JJ; Razavian M; Kim HY; Ye Y; Golestani R; Toczek J; Zhang J; Sadeghi MM
Sci Rep; 2016 Sep; 6():32659. PubMed ID: 27619752
[TBL] [Abstract][Full Text] [Related]
50. Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis.
Bouvet C; Moreau S; Blanchette J; de Blois D; Moreau P
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):856-62. PubMed ID: 18292396
[TBL] [Abstract][Full Text] [Related]
51. Influence of species, environmental factors, and tissue cellularity on calcification of porcine aortic wall tissue.
Meuris B; Ozaki S; Herijgers P; Verbeken E; Flameng W
Semin Thorac Cardiovasc Surg; 2001 Oct; 13(4 Suppl 1):99-105. PubMed ID: 11805957
[TBL] [Abstract][Full Text] [Related]
52. In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate.
Sheth RA; Maricevich M; Mahmood U
Atherosclerosis; 2010 Sep; 212(1):181-7. PubMed ID: 20542274
[TBL] [Abstract][Full Text] [Related]
53. Calcification of allograft aortic wall in a rat subdermal model. Pathophysiology and inhibition by Al3+ and aminodiphosphonate preincubations.
Webb CL; Nguyen NM; Schoen FJ; Levy RJ
Am J Pathol; 1992 Aug; 141(2):487-96. PubMed ID: 1497095
[TBL] [Abstract][Full Text] [Related]
54. Matrix metalloproteinase inhibition causes luminal narrowing and ring thickening in the cricoid cartilage.
Martinez-Alvernia EA; Mankarious LA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):510-5. PubMed ID: 20304269
[TBL] [Abstract][Full Text] [Related]
55. Arterial calcifications in uraemic rats treated with 1-alpha-hydroxycholecalciferol and parathyroidectomy.
Krog M; Ejerblad S; Eriksson I; Johansson H
Scand J Urol Nephrol; 1984; 18(3):227-39. PubMed ID: 6494830
[TBL] [Abstract][Full Text] [Related]
56. Phosphocitrate and its analogue N-sulpho-2-amino tricarballylate inhibit aortic calcification.
Shankar R; Crowden S; Sallis JD
Atherosclerosis; 1984 Aug; 52(2):191-8. PubMed ID: 6477671
[TBL] [Abstract][Full Text] [Related]
57. The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats.
Price PA; Buckley JR; Williamson MK
J Nutr; 2001 Nov; 131(11):2910-5. PubMed ID: 11694617
[TBL] [Abstract][Full Text] [Related]
58. Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension.
Castro MM; Tanus-Santos JE; Gerlach RF
Pharmacol Res; 2011 Dec; 64(6):567-72. PubMed ID: 21514386
[TBL] [Abstract][Full Text] [Related]
59. The matrix metalloproteinases 2 and 9 initiate uraemic vascular calcifications.
Hecht E; Freise C; Websky KV; Nasser H; Kretzschmar N; Stawowy P; Hocher B; Querfeld U
Nephrol Dial Transplant; 2016 May; 31(5):789-97. PubMed ID: 26333546
[TBL] [Abstract][Full Text] [Related]
60. Effect of Doxycycline on Progression of Arterial Calcification in the Noninvasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA(3)CT).
Kim TI; Kostiuk V; Olson SL; Curci JA; Matsumura JS; Baxter BT; Blackwelder WC; Terrin ML; Guzman RJ
Ann Vasc Surg; 2024 Jul; 104():1-9. PubMed ID: 37356652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
